OPC writes:

"My hunch is neither the data nor the trial results or approval have anything to do w/ the reason this hasn't been partnered yet. It's all profit splits, margins, capital outlay and rights/obligations. I don't think this delay has anything to do w/ afrezza."

That could very well be true; trouble is, it's hard to know just how aggressive each side has been - it's possible that to have done a deal or to do one anytime soon would be viewed as disastrous - at that point, the criticism would be focused on what a poor negotiator Al is.